PortfoliosLab logoPortfoliosLab logo
SMMT vs. LUG.TO
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

SMMT vs. LUG.TO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Summit Therapeutics Inc. (SMMT) and Lundin Gold Inc. (LUG.TO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Different Trading Currencies

SMMT is traded in USD, while LUG.TO is traded in CAD. To make them comparable, the LUG.TO values have been converted to USD using the latest available exchange rates.

Returns By Period

In the year-to-date period, SMMT achieves a -19.33% return, which is significantly higher than LUG.TO's -27.87% return. Over the past 10 years, SMMT has underperformed LUG.TO with an annualized return of 4.15%, while LUG.TO has yielded a comparatively higher 31.76% annualized return.


SMMT

1D
-4.47%
1M
-21.96%
YTD
-19.33%
6M
-24.24%
1Y
-31.47%
3Y*
100.52%
5Y*
13.84%
10Y*
4.15%

LUG.TO

1D
0.15%
1M
-15.65%
YTD
-27.87%
6M
-24.20%
1Y
17.78%
3Y*
76.39%
5Y*
49.60%
10Y*
31.76%
*Multi-year figures are annualized to reflect compound growth (CAGR)

SMMT vs. LUG.TO - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
SMMT
Summit Therapeutics Inc.
-19.33%-1.99%583.72%-38.59%57.99%-42.77%193.75%39.13%-89.62%29.44%
LUG.TO
Lundin Gold Inc.
-27.87%309.94%76.65%32.70%22.82%-4.62%34.40%74.11%1.61%-7.62%

Correlation

The correlation between SMMT and LUG.TO is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.19

Correlation (3Y)
Calculated over the trailing 3-year period

0.14

Correlation (5Y)
Calculated over the trailing 5-year period

0.09

Correlation (10Y)
Calculated over the trailing 10-year period

0.07

Correlation (All Time)
Calculated using the full available price history since Mar 5, 2015

0.06

The correlation between SMMT and LUG.TO shifts across timeframes, from 0.06 (all time) to 0.19 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

SMMT:

$10.94B

LUG.TO:

CA$19.02B

EPS

SMMT:

-$1.60

LUG.TO:

CA$3.77

PB Ratio

SMMT:

20.04

LUG.TO:

13.96

Total Revenue (TTM)

SMMT:

$0.00

LUG.TO:

CA$2.00B

Gross Profit (TTM)

SMMT:

-$83.36K

LUG.TO:

CA$1.41B

EBITDA (TTM)

SMMT:

-$738.34M

LUG.TO:

CA$1.43B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SMMT vs. LUG.TO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SMMT
SMMT Risk / Return Rank: 2525
Overall Rank
SMMT Sharpe Ratio Rank: 2424
Sharpe Ratio Rank
SMMT Sortino Ratio Rank: 2828
Sortino Ratio Rank
SMMT Omega Ratio Rank: 2828
Omega Ratio Rank
SMMT Calmar Ratio Rank: 2121
Calmar Ratio Rank
SMMT Martin Ratio Rank: 2424
Martin Ratio Rank

LUG.TO
LUG.TO Risk / Return Rank: 5454
Overall Rank
LUG.TO Sharpe Ratio Rank: 5555
Sharpe Ratio Rank
LUG.TO Sortino Ratio Rank: 5252
Sortino Ratio Rank
LUG.TO Omega Ratio Rank: 5151
Omega Ratio Rank
LUG.TO Calmar Ratio Rank: 5555
Calmar Ratio Rank
LUG.TO Martin Ratio Rank: 5858
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SMMT vs. LUG.TO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Summit Therapeutics Inc. (SMMT) and Lundin Gold Inc. (LUG.TO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


SMMTLUG.TODifference
Sharpe ratioReturn per unit of total volatility

-0.74

Sortino ratioReturn per unit of downside risk

-0.94

Omega ratioGain probability vs. loss probability

0.98

1.10

-0.12

Calmar ratioReturn relative to maximum drawdown

-0.60

0.49

-1.09

Martin ratioReturn relative to average drawdown

-0.92

1.31

-2.22

SMMT vs. LUG.TO - Sharpe Ratio Comparison

The current SMMT Sharpe Ratio is -0.42, which is lower than the LUG.TO Sharpe Ratio of 0.32. The chart below compares the historical Sharpe Ratios of SMMT and LUG.TO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


SMMTLUG.TODifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.42

0.32

-0.74

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.08

1.07

-0.99

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.03

0.73

-0.70

Sharpe Ratio (All Time)

Calculated using the full available price history

0.02

0.10

-0.08

Drawdowns

SMMT vs. LUG.TO - Drawdown Comparison

The maximum SMMT drawdown since its inception was -95.75%, roughly equal to the maximum LUG.TO drawdown of -95.13%. Use the drawdown chart below to compare losses from any high point for SMMT and LUG.TO.


Loading charts...

Drawdown Indicators


SMMTLUG.TODifference

Max Drawdown

Largest peak-to-trough decline

-95.75%

-95.13%

-0.62%

Max Drawdown (1Y)

Largest decline over 1 year

-52.76%

-36.21%

-16.55%

Max Drawdown (3Y)

Largest decline over 3 years

-62.26%

-36.21%

-26.05%

Max Drawdown (5Y)

Largest decline over 5 years

-91.78%

-43.37%

-48.41%

Max Drawdown (10Y)

Largest decline over 10 years

-95.75%

-46.50%

-49.25%

Current Drawdown

Current decline from peak

-61.55%

-36.12%

-25.43%

Average Drawdown

Average peak-to-trough decline

-57.64%

-71.96%

+14.32%

Ulcer Index

Depth and duration of drawdowns from previous peaks

34.32%

13.66%

+20.66%

Volatility

SMMT vs. LUG.TO - Volatility Comparison

Summit Therapeutics Inc. (SMMT) has a higher volatility of 22.47% compared to Lundin Gold Inc. (LUG.TO) at 17.81%. This indicates that SMMT's price experiences larger fluctuations and is considered to be riskier than LUG.TO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


SMMTLUG.TODifference

Volatility (1M)

Calculated over the trailing 1-month period

22.47%

17.81%

+4.66%

Volatility (6M)

Calculated over the trailing 6-month period

56.53%

41.78%

+14.75%

Volatility (1Y)

Calculated over the trailing 1-year period

75.95%

56.18%

+19.77%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

185.12%

46.83%

+138.29%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

144.63%

43.76%

+100.87%

Dividends

SMMT vs. LUG.TO - Dividend Comparison

SMMT has not paid dividends to shareholders, while LUG.TO's dividend yield for the trailing twelve months is around 5.30%.


PositionTTM2025202420232022
LUG.TO
Lundin Gold Inc.
5.30%3.35%2.69%3.26%1.97%
SMMT
Summit Therapeutics Inc.
0.00%0.00%0.00%0.00%0.00%

Financials

SMMT vs. LUG.TO - Financials Comparison

This section allows you to compare key financial metrics between Summit Therapeutics Inc. and Lundin Gold Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00100.00M200.00M300.00M400.00M500.00M600.00M202220232024202520260
567.38M
(SMMT) Total Revenue
(LUG.TO) Total Revenue
Please note, different currencies. SMMT values in USD, LUG.TO values in CAD

Frequently Asked Questions


SMMT and LUG.TO have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for SMMT and LUG.TO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer